abbvie.maxnet-tech.com Open in urlscan Pro
100.8.255.43  Public Scan

URL: https://abbvie.maxnet-tech.com/
Submission: On March 10 via api from US — Scanned from US

Form analysis 0 forms found in the DOM

Text Content

July 9th & July 10th,


PLEASE JOIN US FOR A NATIONAL WEBINAR WITH AN IBD EXPERT TO HEAR THE LATEST
INFORMATION ABOUT THE TREATMENT OF UC.

View Schedule

Conference Date


COUNT EVERY SECOND
UNTIL THE EVENT

30

Days

20

Hrs

18

Mins

15

Secs


ABOUT CONFERENCE

In accordance with the PhRMA Code on Interactions with Healthcare Professionals,
attendance at this program is limited to healthcare professionals who practice
in relevant specialties. AbbVie tracks and reports payments and transfers of
value to healthcare professionals under applicable state and federal reporting
obligations. Alcohol will no longer be provided by AbbVie at programs. Scan the
QR code to register for our National Webinars

 * Write On Your Business Card
 * Advertising Outdoors
 * Effective Advertising Pointers
 * Kook 2 Directory Add Url Free

Discover Now


WHO’S SPEAKING

This is your opportunity to experience exciting data showcasing AbbVie’s
commitment to patients with IBD, presented by:

MARLA DUBINSKY

Speaker

MIGUEL REGUEIRO

Speaker

REMO PANACCIONE

Speaker


OUR SCHEDULE

Do not miss anything topic about the event

 * DAY 1
   
   Tuesday, July 9th, 2024

 * DAY 2
   
   Wednesday, July 10th, 2024

   

MARLA DUBINSKY,

 * Marla Dubinsky
 * MarlaDubinsky@gmail.com

 * 11:00 am - 12:00 PM
 * 59 Breanne Canyon Suite, USA

 * 12:30 am - 01:30 PM
 * 59 Breanne Canyon Suite, USA

 * 06:30 am - 07:30 PM
 * 59 Breanne Canyon Suite, USA

 * 08:30 am - 09:90 PM
 * 59 Breanne Canyon Suite, USA

MIGUEL REGUEIRO

 * Miguel Regueiro
 * john@Colorlib.com

 * 11:00 am - 12:00 PM
 * 59 Breanne Canyon Suite, USA

 * 12:30 am - 01:30 PM
 * 59 Breanne Canyon Suite, USA

 * 06:30 am - 07:30 PM
 * 59 Breanne Canyon Suite, USA

 * 08:30 am - 09:90 PM
 * 59 Breanne Canyon Suite, USA

REMO PANACCIONE

 * Remo Panaccione
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

MARLA DUBINSKY

 * Marla Dubinsky
 * MarlaDubinsky@gmail.com

 * 11:00 am - 12:00 PM
 * 59 Breanne Suite, USA

MARLA DUBINSKY

 * Marla Dubinsky
 * MarlaDubinsky@gmail.com

 * 2:00 PM - 3:00 PM
 * 59 Breanne Canyon Suite, USA

MARLA DUBINSKY

 * Marla Dubinsky
 * MarlaDubinsky@gmail.com

 * 5:00 PM - 6:00 PM
 * 59 Breanne Canyon Suite, USA

MARLA DUBINSKY

 * Marla Dubinsky
 * MarlaDubinsky@gmail.com

 * 6:30 PM - 7:30 PM
 * 59 Breanne Canyon Suite, USA

DEALING WITH INTERMEDIATE PEOPLE

 * John Smith
 * john@Colorlib.com

 * 08:00 PM - 10:00 AM
 * 59 Breanne Canyon Suite, USA

V7 DIGITAL PHOTO PRINTING

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

BEYOND THE NAKED EYE

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

INFLUENCING THE INFLUENCER

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

DEALING WITH EXPERT PEOPLE

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

V7 DIGITAL PHOTO PRINTING

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

BEYOND THE NAKED EYE

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

INFLUENCING THE INFLUENCER

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

DEALING WITH TOO DIFFICULT PEOPLE

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

V7 DIGITAL PHOTO PRINTING

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

BEYOND THE NAKED EYE

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

INFLUENCING THE INFLUENCER

 * John Smith
 * john@Colorlib.com

 * 08:00 am - 10:00 AM
 * 59 Breanne Canyon Suite, USA

‹›

 * Home
 * Speakers
 * Schedule
 * Contact

Copyright © 2024 ©2024 AbbVie. All rights reserved. US-XXXX-XXXXXX January 2024